The U.S. Food and Drug Administration has provided a detailed description of proposed effective dates for Unique Device Identification (UDI) requirements on its Web site.
New Institute of Medicine report points to a new way of talking about and addressing problematic meds globally, with packaging smack dab in the middle of the issue.
Nanotechnology, combination products, and regulatory strategies frame the future in medical compliance issues, as noted in Feb. 12 MD&M West conference track.